Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1633 1653 1699
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18382626 | CD47 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES | Non-Final OA | President and Fellows of Harvard College |
| 18658077 | METHODS OF TREATING MITOCHONDRIAL DISORDERS | Non-Final OA | The Regents of the University of California |
| 17440116 | AUGMENTATION OF T-CELL ACTIVATION BY OSCILLATORY FORCES AND ENGINEERED ANTIGEN-PRESENTING CELLS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17047975 | COMPOSITIONS AND METHODS FOR CYTOTOXIC CD4+ T CELLS | Non-Final OA | The Regents of the University of California |
| 18029750 | METHODS FOR IDENTIFYING MODULATORS OF NATURAL KILLER CELL INTERACTIONS | Non-Final OA | The Johns Hopkins University |
| 17784935 | ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF | Final Rejection | The General Hospital Corporation |
| 17760245 | CYTOTOXIC T CELLS DERIVED FROM HUMAN T CELL-DERIVED IPS CELLS | Non-Final OA | THE UNIVERSITY OF TOKYO |
| 17928674 | COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS USING CRISPR-BASED BASE EDITOR SYSTEMS | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18660178 | METHODS FOR THE LONG-TERM EXPANSION OF GRANULOCYTE-MACROPHAGE PROGENITORS AND APPLICATIONS THEREOF | Non-Final OA | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 18276416 | GENERATION OF INDUCED PLURIPOTENT STEM CELL LINES FROM HUMAN PATIENTS WITH MUTATIONS IN THE GLUCOKINASE GENE | Non-Final OA | Qatar Foundation for Education, Science and Community Development |
| 18626460 | RECRUITMENT METHODS AND COMPOUNDS, COMPOSITIONS AND SYSTEMS FOR RECRUITMENT | Non-Final OA | Pairwise Plants Services, Inc. |
| 17759271 | BI-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CD83 AND INTERLEUKIN 6 RECEPTOR | Final Rejection | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 18517525 | SEPARATION DEVICE AND METHOD FOR SEPARATING TO-BE-SEPARATED MATERIAL USING SAME | Non-Final OA | NISSAN CHEMICAL CORPORATION |
| 18748469 | OSTEOGENIC COMPOSITIONS AND METHODS OF MAKING THE SAME | Non-Final OA | Alphatec Spine, Inc. |
| 18565425 | DUAL-LAYER CULTURE SUBSTRATE | Non-Final OA | WASEDA UNIVERSITY |
| 17774088 | GENERATION OF CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FROM STEM CELLS AND THERAPEUTIC USES THEREOF | Final Rejection | City of Hope |
| 17176422 | APPARATUS FOR SEPARATING THE CELLULAR AND LIQUID PORTIONS OF A WHOLE BLOOD SAMPLE | Final Rejection | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY |
| 18517066 | METHOD FOR INDUCING AND DETECTING SOLUBLE LOX-1 (sLOX-1) IN CULTURED BLOOD CLOTS | Non-Final OA | GEORGE MASON UNIVERSITY |
| 18252627 | CULTURED ADIPOSE TISSUE | Non-Final OA | Trustees of Tufts College |
| 18571568 | METHOD FOR PRODUCING MULTINUCLEATED MEGAKARYOCYTE WITH ENHANCED PLATELET PRODUCTION CAPABILITY, METHOD FOR PRODUCING PLATELETS, METHOD FOR PRODUCING PLATELET PREPARATION, AND METHOD FOR PRODUCING BLOOD PREPARATION | Non-Final OA | Megakaryon Corporation |
| 17915802 | Cell | Non-Final OA | AUTOLUS LIMITED |
| 18513435 | PROTEIN-FREE SEMEN CRYOPRESERVATION | Final Rejection | University of Saskatchewan |
| 18037478 | EXTRACELLULAR VESICLES DERIVED FROM CARDIOSPHERE-DERIVED CELLS AS ANTI-SHOCK THERAPEUTICS | Non-Final OA | Tiffani C. Chance |
| 17912480 | ISCHEMIC HEART DISEASE ANIMAL MODEL USING 3-DIMENSIONAL BIOPRINTED OCCLUDE, AND MANUFACTURING METHOD THEREFOR | Non-Final OA | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY |
| 17758960 | METHODS AND COMPOSITIONS FOR STIMULATION OF CHIMERIC ANTIGEN RECEPTOR T CELLS WITH HAPTEN LABELLED CELLS | Final Rejection | Seattle Children's Hospital (dba Seattle Children's Research Institute) |
| 18356949 | ENHANCEMENT OF ADOPTIVE CELL TRANSFER | Non-Final OA | cellvie Inc. |
| 17012748 | ENGINEERING OF IMMUNE CELLS FOR EX VIVO CELL THERAPY APPLICATIONS | Non-Final OA | Avectas Limited |
| 18254549 | GENERATION OF NEURAL PROGENITOR CELLS FROM EMBRYONIC STEM CELLS OR INDUCED PLURIPOTENT STEM CELLS | Final Rejection | Shanghai Hopstem Biomedicine Co., Ltd. |
| 18038207 | METHODS FOR PRODUCING MATURE CHONDROCYTES AND COMPOSITION CONTAINING MATURE CHONDROCYTES | Non-Final OA | REGENESIS SCIENCE CO., LTD. |
| 18320900 | AN ENGINEERED TWO-PART CELLULAR DEVICE FOR DISCOVERY AND CHARACTERISATION OF T-CELL RECEPTOR INTERACTION WITH COGNATE ANTIGEN | Non-Final OA | Genovie AB |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy